Raiffeisen Bank International’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121M Sell
136,080
-5,808
-4% -$5.89M 1.73% 8
2025
Q4
$153M Sell
141,888
-9,335
-6% -$8.93M 1.97% 7
2025
Q3
$110M Buy
151,223
+5,977
+4% +$4.45M 1.46% 8
2025
Q2
$115M Sell
145,246
-21,609
-13% -$16.8M 1.71% 7
2025
Q1
$137M Sell
166,855
-3,316
-2% -$2.76M 2.19% 5
2024
Q4
$132M Buy
+170,171
New +$141M 2% 7

Other funds holding LLY

Raiffeisen Bank International's LLY Position: Q1 2026 in Review

Raiffeisen Bank International reduced its Eli Lilly (LLY) stake by 4.1% in Q1 2026, selling an estimated $5.89M and leaving 136,080 shares worth $121M. The position accounts for 1.73% of the portfolio, ranked #8.

Raiffeisen Bank International first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $153M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Raiffeisen Bank International held 136,080 shares of Eli Lilly worth $121M as of Q1 2026.
  • Raiffeisen Bank International sold 5,808 Eli Lilly shares in Q1 2026, an estimated $5.89M.
  • Eli Lilly made up 1.73% of Raiffeisen Bank International's portfolio in Q1 2026, its #8 holding.
  • Raiffeisen Bank International first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Raiffeisen Bank International's Eli Lilly position peaked at $153M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.